Welcome to our dedicated page for Gabelli Health & Wellness SEC filings (Ticker: GRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From oncology breakthroughs to plant-based nutrition, Gabelli Healthcare & WellnessRx Trust (GRX) discloses how it positions capital inside the fast-moving health and wellness universe. Whether you are comparing portfolio turnover or checking how much of the fund is allocated to medical devices versus pharmaceuticals, the details live inside GRX’s SEC docket—now decoded for you on Stock Titan.
Our platform gathers every form—annual report (N-CSR or the familiar 10-K), quarterly holdings (10-Q or N-PORT), 8-K material event notices, proxy statements on executive compensation, and the Form 4 insider trading filings—all in one feed with real-time EDGAR updates. AI-powered summaries translate dense language into plain English, so “Gabelli Healthcare & WellnessRx Trust SEC filings explained simply” is more than a promise—it is a click away. You will also find natural language answers to searches like “Gabelli Healthcare & WellnessRx Trust insider trading Form 4 transactions” or “understanding Gabelli Healthcare & WellnessRx Trust SEC documents with AI.”
Investors use these disclosures to track discount-control plans, monitor “Gabelli Healthcare & WellnessRx Trust executive stock transactions Form 4,” and study segment weightings before earnings season. Want the next “Gabelli Healthcare & WellnessRx Trust quarterly earnings report 10-Q filing” or an alert when management files an 8-K? Our AI flags the numbers that drive dividend sustainability and highlights risk factors without the jargon. Explore:
- “Gabelli Healthcare & WellnessRx Trust annual report 10-K simplified” for sector allocation trends
- “Gabelli Healthcare & WellnessRx Trust 8-K material events explained” to gauge portfolio shifts
- “Gabelli Healthcare & WellnessRx Trust proxy statement executive compensation” for governance insights
- “Gabelli Healthcare & WellnessRx Trust earnings report filing analysis” with instant AI commentary
- “Gabelli Healthcare & WellnessRx Trust Form 4 insider transactions real-time” to track manager buys and sells
Complex filings, clear answers—delivered by Stock Titan’s AI in seconds.
Sit Investment Associates, Inc. and its subsidiary Sit Fixed Income Advisors II, LLC reported shared beneficial ownership of 833,756 shares of The Gabelli Healthcare & WellnessRx Trust common stock, representing 5.4% of the class based on 15,447,824 shares outstanding as of June 30, 2025. The filing states the shares are held in client accounts managed by the advisers and that the advisers disclaim beneficial ownership under Rule 13d-4. Both filers report 0 sole voting and dispositive power and 833,756 shares of shared voting and dispositive power. The filing includes a joint filing agreement and a certification by Paul E. Rasmussen as Vice President.
Saba Capital Management, L.P. reported two open-market purchases of Gabelli Healthcare & WellnessRx Trust (GRX) common stock on 09/11/2025 and 09/12/2025 at $9.43 per share. The first purchase was 6,147 shares, bringing indirect beneficial ownership to 2,043,303 shares; the second added 7,732 shares, increasing indirect ownership to 2,051,035. The filing lists the reporting person as a Director and a 10% owner and is signed by Zachary Gindes and Boaz Weinstein on 09/15/2025.
Saba Capital Management, L.P. and reporting person Boaz Weinstein reported an acquisition of Common Stock of Gabelli Healthcare & WellnessRx Trust (GRX). On 08/25/2025 they purchased 11,330 shares at $9.48 per share, and the filing shows 2,037,156 shares beneficially owned indirectly following the transaction. The Form 4 is signed and dated 08/26/2025 by Saba Capital and Boaz Weinstein.
The filing reports that Saba Capital Management, L.P. and Boaz Weinstein, both identified as a director and 10% owner, purchased 19,101 shares of Gabelli Healthcare & WellnessRx Trust (GRX) on 08/21/2025 at a price of $9.43 per share. After the transaction, the reporting persons are shown as beneficially owning 2,025,826 shares indirectly. The Form 4 reflects a routine insider purchase disclosed under Section 16.
FAQ
What is the current stock price of Gabelli Health & Wellness (GRX)?
What is the market cap of Gabelli Health & Wellness (GRX)?
